Cargando...
Arbekacin treatment of a patient infected with a Pseudomonas putida producing a metallo-beta-lactamase
Treatment of infections caused by multidrug-resistant Pseudomonas species is difficult because few antibiotics active against such organisms are available. Arbekacin, a relatively new aminoglycoside, is effective against Pseudomonas spp. in vitro. However, no clinical report on arbekacin treatment o...
Gardado en:
| Publicado en: | J Intensive Care |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4336246/ https://ncbi.nlm.nih.gov/pubmed/25705398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2052-0492-1-3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|